Food noise is persistent, unwanted thinking about food that keeps interrupting the day. It's a patient phrase, not a medical diagnosis.
It might mean planning the next meal while still eating, or having food decisions crowd out work and conversation. Hunger and cravings can be part of it. What stands out is how often the thoughts return and how hard they are to set aside.
What is food noise compared with hunger?
Hunger, cravings and food noise overlap, but they describe different experiences.
| Experience | What the phrase describes |
|---|---|
| Hunger | The drive to eat, often with physical sensations such as an empty stomach |
| A craving | A strong desire for a particular food |
| Food noise | Repeated food thoughts that feel intrusive or disruptive |
Thinking about dinner or enjoying dessert isn't automatically a problem. The useful distinction is whether food thoughts keep taking attention from the rest of life. Someone can describe food noise without feeling physically hungry.
Do GLP-1 medicines quiet food noise?
They may help with related experiences, especially cravings and eating control. That doesn't mean every person will feel the same change.
GLP-1 is a gut hormone involved in fullness after eating. Semaglutide mimics its signal. Food reward means how appealing food feels and how strongly it draws attention; researchers study this alongside hunger.
A 2021 trial in Diabetes, Obesity and Metabolism followed 72 adults with obesity for 20 weeks. Participants receiving semaglutide reported better eating control and fewer, weaker cravings than those receiving placebo, an inactive comparison treatment. These were questionnaire results, not a direct measurement of food noise. (Friedrichsen et al.)
The longer STEP 5 analysis, published in Obesity in 2023, included 174 questionnaire participants followed for 104 weeks. Its 19-question Control of Eating Questionnaire asked about cravings, hunger and eating control. Craving control improved compared with placebo through two years. Hunger and fullness differences reached statistical significance, meaning they met the study's cutoff for evidence beyond chance, at week 20 alone. (Wharton et al.)
The analysis tested many comparisons without adjusting for the greater chance of false alarms. Individual findings need caution. The broader explanation of how semaglutide works covers its other effects.
How researchers started measuring food noise
A 2023 paper in Nutrients brought the patient phrase into a scientific model. It discussed food cue reactivity: how sights, smells or other reminders of food prompt a response. That was a proposed explanation, not a diagnostic test.
In 2025, researchers published a five-item Food Noise Questionnaire in Obesity. They analyzed responses from 396 adults. The questions capture intrusive thoughts and their disruption to daily life, including experiences without an obvious food reminder. Results supported consistent measurement, but the authors said its usefulness in clinical care needed further study. (Diktas et al.)
As of September 30, 2026, the day this article was written, a review published online September 22 in Appetite still describes uncertainty about food noise's causes. It discusses several possible explanations, including hunger signals and difficulty setting thoughts aside. Those explanations remain proposals.
A questionnaire can help describe an experience. Its score doesn't establish a diagnosis or decide whether medication fits.
What about tirzepatide and food cravings?
Tirzepatide acts on GLP-1 and GIP, another hormone released after eating. Human studies have measured changes in cravings and how people respond to available food.
A six-week trial published in Nature Medicine in 2025 enrolled 114 adults with overweight or obesity, without diabetes. Compared with placebo, tirzepatide was associated with lower hunger, fewer cravings and less tendency to overeat by week three. Participants also reported less pull from food in their surroundings. (Martin et al.)
That supports an effect on eating behavior. It doesn't show that everyone experiences complete mental quiet, or identify one cause of intrusive thoughts. How tirzepatide works explains its two hormone targets.
What the new brain-scan findings add
As of September 30, 2026, the day this article was written, Novo Nordisk's September 30 announcement reports changed responses to food images with investigational CagriSema using fMRI, a brain scan that tracks blood-flow changes; the CagriSema food-noise findings explain that development.
Brain scans offer clues about how food draws attention. They don't directly count someone's intrusive thoughts or predict an individual response. Other appetite-focused drugs are still in testing too, including Novo Nordisk's zenagamtide, a single investigational molecule that acts on both GLP-1 and amylin receptors.
When food thoughts deserve a closer look
Food noise alone doesn't mean someone has an eating disorder. The pattern around it matters.
The National Institute of Mental Health describes warning signs such as severe food restriction, repeated loss of control over eating, vomiting or laxative use after eating, and excessive exercise. Eating disorders can occur at any body weight.
Persistent thoughts accompanied by those behaviors, strong shame or disruption to daily life are reasons to talk to a provider. A primary care clinician can help arrange an assessment with a mental health professional.
Treatment for an eating disorder can include therapy, nutritional counseling and medical monitoring. A quieter appetite doesn't establish that the underlying problem has been addressed.
What a treatment conversation should cover
The useful starting point is what the thoughts interrupt: concentration, sleep, social meals or everyday decisions. Their frequency, how upsetting they feel and any episodes of loss of control give a provider more information than the phrase alone.
A discussion can also cover current medicines, eating patterns and whether weight-management treatment fits the person's health needs. Semaglutide may be part of that conversation. Enjoying food and feeling hungry can still be ordinary parts of eating during treatment.
For someone already prescribed medication, the conversation includes nutrition, side effects and what has actually changed. The aim is a manageable relationship with food, rather than judging treatment by total silence.
What a Promise visit can decide
The studies above evaluated manufactured or study-supplied medicines. They don't establish identical results for every compounded preparation, a medicine prepared by a pharmacy for a prescription.
Semaglutide and tirzepatide prescribed through Promise are dispensed by a licensed U.S. compounding pharmacy as compounded medications, which are different from an FDA-approved product: the formulations offered here are not FDA-approved.
As of September 30, 2026, the day this article was written, the FDA's compounding guidance states that the agency does not verify compounded drugs' safety, effectiveness or quality before sale. A licensed provider may still prescribe a compounded formulation; that decision is between the patient and the doctor.
At Promise, a licensed U.S. provider reviews every request and prescribes or declines based on medical eligibility. Not everyone qualifies.
Describing the thoughts, the eating patterns around them and their effect on daily life gives that visit a concrete starting point.
